Hengrui Medicine (600276.SH): Injection drugs such as SHR-A1811 approved for clinical trials.

date
06/06/2025
Zhtng cijng APP xn, hng ru yyo (600276.SH) fb gnggo, jnr, gngs j z gngs szhu shngdy shngw yyo yuxin gngs, shnghi shngd yyo yuxin gngs shudo guji yopn jind gunl j (jinchng "guji yojin j") hkn qinf guny zhsh yng SHR-A1811, d bi l dn kng zhsh y, pnggu sun f m tn jion de "yow lnchuns shyn pzh tngzh sh", jingy jnr kizhn lnchuns shyn. Jt wi: zhsh yng SHR-A1811 linh kngzhngbng yow zhlio shtzhong de kifng, du zhngxn I b / II q lnchuns ynji.